These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24564054)

  • 1. Salmonella enterica arthritis in a patient with rheumatoid arthritis receiving anti-tumour necrosis factor therapy.
    Bubonja-Sonje M; Rubinic D; Anic F; Novak S; Vuckovic D; Abram M
    West Indian Med J; 2013 Mar; 62(3):270-2. PubMed ID: 24564054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.
    Netea MG; Radstake T; Joosten LA; van der Meer JW; Barrera P; Kullberg BJ
    Arthritis Rheum; 2003 Jul; 48(7):1853-7. PubMed ID: 12847679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septic arthritis due to Salmonella enteritidis associated with infliximab use.
    Katsarolis I; Tsiodras S; Panagopoulos P; Giannitsioti E; Skarantavos G; Ioannidis T; Giamarellou H
    Scand J Infect Dis; 2005; 37(4):304-5. PubMed ID: 15804667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal Salmonella enteritidis septicaemia in a rheumatoid arthritis patient treated with a TNF-alpha antagonist.
    Rijkeboer A; Voskuyl A; Van Agtmael M
    Scand J Infect Dis; 2007; 39(1):80-3. PubMed ID: 17366020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated Salmonella paratyphi infection in a rheumatoid arthritis patient treated with infliximab.
    Bassetti M; Nicco E; Delfino E; Viscoli C
    Clin Microbiol Infect; 2010 Jan; 16(1):84-5. PubMed ID: 19723134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Septic arthritis due to Roseomonas mucosa in a rheumatoid arthritis patient receiving infliximab therapy.
    Sipsas NV; Papaparaskevas J; Stefanou I; Kalatzis K; Vlachoyiannopoulos P; Avlamis A
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):343-5. PubMed ID: 16626905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.
    Galloway JB; Hyrich KL; Mercer LK; Dixon WG; Ustianowski AP; Helbert M; Watson KD; Lunt M; Symmons DP;
    Ann Rheum Dis; 2011 Oct; 70(10):1810-4. PubMed ID: 21784730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    van Dartel SA; Fransen J; Kievit W; Flendrie M; den Broeder AA; Visser H; Hartkamp A; van de Laar MA; van Riel PL
    Ann Rheum Dis; 2013 Jun; 72(6):895-900. PubMed ID: 22887849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J
    J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late infection of total knee arthroplasty inflamed by anti-TNFalpha, Infliximab therapy in rheumatoid arthritis.
    Yurube T; Takahi K; Owaki H; Fuji T; Kurosaka M; Doita M
    Rheumatol Int; 2010 Jan; 30(3):405-8. PubMed ID: 19449010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs.
    Momohara S; Kawakami K; Iwamoto T; Yano K; Sakuma Y; Hiroshima R; Imamura H; Masuda I; Tokita A; Ikari K
    Mod Rheumatol; 2011 Oct; 21(5):469-75. PubMed ID: 21318306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.
    Kroesen S; Widmer AF; Tyndall A; Hasler P
    Rheumatology (Oxford); 2003 May; 42(5):617-21. PubMed ID: 12709536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of rheumatoid arthritis presenting with pulmonary tuberculosis].
    Katoh K; Taniguchi H; Okouchi A; Kudo M; Kawai T
    Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):782-6. PubMed ID: 15455955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overwhelming parasitemia with Plasmodium falciparum infection in a patient receiving infliximab therapy for rheumatoid arthritis.
    Geraghty EM; Ristow B; Gordon SM; Aronowitz P
    Clin Infect Dis; 2007 May; 44(10):e82-4. PubMed ID: 17443458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Hochman D; Wolff B
    JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Callegari PE; Schaible TF; Boscia JA
    JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Costenbader KH; Glass R; Cui J; Shadick N
    JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the risk of infections in different anti-TNF agents: a meta-analysis.
    Liao H; Zhong Z; Liu Z; Zou X
    Int J Rheum Dis; 2017 Feb; 20(2):161-168. PubMed ID: 28160418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.